- Tagaram HR. Watson AM. Lemonnier FA. Staveley-O'Carroll K. Tevethia SS. Schell TD. An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants. 2008 Jun 20. Virology. 376(1):183-90.
|
- Yorty JL. Tevethia SS. Schell TD. Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors. 2008 Jun. Cancer Immunol Immunother. 57(6):883-95.
|
- Otahal P. Knowles BB. Tevethia SS. Schell TD. Anti-CD40 conditioning enhances the T(CD8) response to a highly tolerogenic epitope and subsequent immunotherapy of simian virus 40 T antigen-induced pancreatic tumors. 2007 Nov 15. J Immunol. 179(10):6686-95.
|
- Mylin LM. Schell TD. Epler M. Kusuma C. Assis D. Matsko C. Smith A. Allebach A. Tevethia SS. Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones. 2007 Jul 20. Virology. 364(1):155-68.
National Center for Research Resources
National Heart, Lung, and Blood Institute
National Cancer Institute |
- Otahal P. Schell TD. Hutchinson SC. Knowles BB. Tevethia SS. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice. 2006 Sep 1. J Immunol. 177(5):3089-99.
National Cancer Institute |
- Ryan CM. Schell TD. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope. 2006 Jul 1. J Immunol. 177(1):255-67.
|
- Hu J. Peng X. Schell TD. Budgeon LR. Cladel NM. Christensen ND. An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection. 2006 Dec 1. J Immunol. 177(11):8037-45.
National Cancer Institute |
- Otahal P. Hutchinson SC. Mylin LM. Tevethia MJ. Tevethia SS. Schell TD. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope. 2005 Jul 15. J Immunol. 175(2):700-12.
National Cancer Institute |
- Barton LF. Runnels HA. Schell TD. Cho Y. Gibbons R. Tevethia SS. Deepe GS. Monaco JJ. Immune defects in 28-kDa proteasome activator gamma-deficient mice. 2004 Mar 15. J Immunol. 172(6):3948-54.
National Institute of Allergy and Infectious Diseases
National Cancer Institute |
- Schell TD. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice. 2004 Feb. J Virol. 78(4):1751-62.
National Cancer Institute |
- Stanic AK. Shashidharamurthy R. Bezbradica JS. Matsuki N. Yoshimura Y. Miyake S. Choi EY. Schell TD. Van Kaer L. Tevethia SS. Roopenian DC. Yamamura T. Joyce S. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. 2003 Nov 1. J Immunol. 171(9):4539-51.
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute |
- Staveley-O'Carroll K. Schell TD. Jimenez M. Mylin LM. Tevethia MJ. Schoenberger SP. Tevethia SS. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. 2003 Jul 15. J Immunol. 171(2):697-707.
National Cancer Institute |
- Anglen CS. Truckenmiller ME. Schell TD. Bonneau RH. The dual role of CD8+ T lymphocytes in the development of stress-induced herpes simplex encephalitis. 2003 Jul. J Neuroimmunol. 140(1-2):13-27.
National Institute of Allergy and Infectious Diseases |
- Schell TD. Mylin LM. Tevethia SS. Joyce S. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes. 2002 Jul. Int Immunol. 14(7):775-82.
National Cancer Institute
National Heart, Lung, and Blood Institute |
- Schell TD. Lippolis JD. Tevethia SS. Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigen. 2001 Feb 1. Cancer Res. 61(3):873-9.
National Cancer Institute |
- Schell TD. Tevethia SS. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen. 2001 Dec 15. J Immunol. 167(12):6947-56.
National Cancer Institute |
- Tevethia S. Beachy T. Schell T. Lippolis J. Newmaster R. Mylin L. Tevethia MJ. Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate. 2001. Dev Biol (Basel). 106:109-21; discussion 143-60.
National Cancer Institute |
- Schell TD. Tevethia SS. Cytotoxic T lymphocytes in SV40 infections. 2001. Methods Mol Biol. 165:243-56.
National Cancer Institute |
- Schell TD. Knowles BB. Tevethia SS. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas. 2000 Jun 1. Cancer Res. 60(11):3002-12.
National Cancer Institute |
- Mylin LM. Schell TD. Roberts D. Epler M. Boesteanu A. Collins EJ. Frelinger JA. Joyce S. Tevethia SS. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. 2000 Aug. J Virol. 74(15):6922-34.
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Heart, Lung, and Blood Institute |
- Schell TD. Mylin LM. Georgoff I. Teresky AK. Levine AJ. Tevethia SS. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. 1999 Jul. J Virol. 73(7):5981-93.
National Cancer Institute |
- Fu TM. Mylin LM. Schell TD. Bacik I. Russ G. Yewdell JW. Bennink JR. Tevethia SS. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. 1998 Feb. J Virol. 72(2):1469-81.
National Cancer Institute |
